Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan
· Delayed Price · Currency is TWD 18.00
+0.05 (0.28%)
Jun 20, 2025, 12:54 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 805.90 million as of June 18, 2025. Its market cap has decreased by -16.86% in one year.
Market Cap
805.90M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
18.00
Market Cap Chart
Since January 12, 2023, TPEX:6917's market cap has decreased from 1.11B to 805.90M, a decrease of -27.57%. That is a compound annual growth rate of -12.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2025 | 805.90M | 4.65% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 175.63B |
| Caliway Biopharmaceuticals | 170.61B |
| Bora Pharmaceuticals Co., LTD. | 81.93B |
| Lotus Pharmaceutical | 57.85B |
| Oneness Biotech | 34.39B |
| Polaris Group | 30.28B |
| Center Laboratories | 27.39B |
| Lumosa Therapeutics | 27.35B |